Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
30%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
IXJ
114
HOLDINGS
10%
ALSO IN PPH
PPH
27
HOLDINGS
42%
ALSO IN IXJ
SECTOR DRIFT (IXJ minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 9.7% | 18.6% | 9.7% |
|
JOHNSON & JOHNSON | 7.1% | 4.5% | 4.5% |
|
MERCK & CO. INC. | 4.5% | 11.0% | 4.5% |
|
ABBVIE INC | 4.9% | 4.5% | 4.5% |
|
PFIZER INC | 2.0% | 5.1% | 2.0% |
IXJ Overweight Relative to PPH
|
UNITEDHEALTH GROUP INC | 3.9% |
 |
NOVARTIS AG | 3.5% |
 |
ASTRAZENECA PLC | 3.0% |
|
AMGEN INC | 2.8% |
|
THERMO FISHER SCIENTIFIC INC | 2.8% |
|
JOHNSON & JOHNSON | 2.6% |
|
ABBOTT LABORATORIES | 2.3% |
|
GILEAD SCIENCES INC | 2.3% |
 |
NOVO NORDISK A/S-B | 1.8% |
|
VERTEX PHARMACEUTICALS INC | 1.7% |
IXJ Underweight Relative to PPH
|
NOVARTIS AG-ADR | -10.4% |
|
ELI LILLY & CO | -8.8% |
|
MERCK & CO. INC. | -6.6% |
|
NOVO-NORDISK A/S-SPONS ADR | -5.0% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -4.0% |
 |
SANOFI-AVENTIS-ADR | -4.0% |
|
ASTRAZENECA PLC-SPONS ADR | -3.6% |
|
MCKESSON CORP | -3.4% |
|
BRISTOL-MYERS SQUIBB CO | -3.3% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -3.2% |